Scott Abraham, MD
Orthopaedic Surgery · Overland Park, KSNPI 1265659296
Payments from drug & device makers
Across 42 payments — averaging $123.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$5K
- Amgen$212
- Pacira Therapeutics, Inc.$94
- Linvatec Corporation$65
- Heron Therapeutics, Inc.$35
- Ferring Pharmaceuticals Inc.$31
- plus $154 from 8 others
What the payments were for
- Speaking & faculty fees$4,51087%
- Food & beverage$68413%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 7 | $4,603 |
| Amgen | 16 | $212 |
| Pacira Therapeutics, Inc. | 4 | $94 |
| Linvatec Corporation | 1 | $65 |
| Heron Therapeutics, Inc. | 2 | $35 |
| Ferring Pharmaceuticals Inc. | 2 | $31 |
| Zimmer Biomet | 2 | $29 |
| Fidia Pharma USA Inc. | 2 | $27 |
| DJO, LLC | 1 | $22 |
| Titan Surgical Group, LLC | 1 | $19 |
| Boston Scientific | 1 | $16 |
| Radius Health, Inc. | 1 | $14 |
| Bioventus LLC | 1 | $14 |
| Pfizer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II BCS$2,610
- NAVIO$1,900
- Navio Surgical System$950
- VERILAST Knee$950
How this compares
$5,194 in reported general payments places this provider in the 55th percentile of 197 orthopaedic surgery providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 225 | $3,116 |
| Celecoxib | 42 | $1,358 |
| Ondansetron OdtOndansetron | 87 | $1,090 |
| Cephalexin | 313 | $1,003 |
| Morphine Sulfate ErMorphine Sulfate | 89 | $422 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 38 | $419 |
| Tramadol Hcl | 78 | $402 |
| Mupirocin | 34 | $282 |
| Ondansetron Hcl | 57 | $278 |
| Gabapentin | 34 | $271 |
| Meloxicam | 101 | $224 |
| Clindamycin Hcl | 21 | $45 |
| Ciprofloxacin Hcl | 12 | $30 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Overland Park
- Alexander BaileyOverland Park$99K
- John BleazardOverland Park$56K
- Cameron LedfordOverland Park$45K
- Jeffrey SalinOverland Park$41K
- Brian KindredOverland Park$18K
- Howard RosenthalOverland Park$13K
- Daniel ProhaskaWichita$1.3M
- James McAteeManhattan$641K
- Jeffrey RandallLawrence$623K
- Brian IpsenGalena$572K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.